BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11468190)

  • 1. Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
    Miura Y; Thoburn CJ; Bright EC; Sommer M; Lefell S; Ueda M; Nakao S; Hess AD
    Blood; 2001 Aug; 98(3):868-76. PubMed ID: 11468190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.
    Hess AD; Bright EC; Thoburn C; Vogelsang GB; Jones RJ; Kennedy MJ
    Blood; 1997 Mar; 89(6):2203-9. PubMed ID: 9058745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
    Miura Y; Thoburn CJ; Bright EC; Chen W; Nakao S; Hess AD
    Blood; 2002 Oct; 100(7):2650-8. PubMed ID: 12239181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Du JW; Gu JY; Liu J; Cen XN; Zhang Y; Ou Y; Chu B; Zhu P
    Leuk Lymphoma; 2007 Aug; 48(8):1618-27. PubMed ID: 17701594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
    Hess AD; Thoburn CJ; Chen W; Horwitz LR
    Biol Blood Marrow Transplant; 2000; 6(1):13-24. PubMed ID: 10707995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
    Hess AD; Thoburn C; Horwitz L
    Transplantation; 1998 Mar; 65(6):785-92. PubMed ID: 9539089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire.
    Margolis DA; Casper JT; Segura AD; Janczak T; McOlash L; Fisher B; Miller K; Gorski J
    Biol Blood Marrow Transplant; 2000; 6(4):408-15. PubMed ID: 10917576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular characteristics of T-cell receptor of clonal expansion of T lymphocytes in leukemia patients after haploidentical bone marrow transplantation].
    Fu YW; Wu DP; Feng YF; Chang WR; Zhu ZL; Zhu P
    Ai Zheng; 2007 Mar; 26(3):236-40. PubMed ID: 17355783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia: usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion.
    Nakao S
    Int J Hematol; 2002 Aug; 76 Suppl 1():274-6. PubMed ID: 12430863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
    Chen W; Thoburn C; Hess AD
    J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
    Hess AD; Horwitz LR; Laulis MK; Fuchs E
    Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
    Hess AD; Jones RC; Santos GW
    Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease.
    Hess AD; Thoburn CJ
    Immunol Rev; 1997 Jun; 157():111-23. PubMed ID: 9255625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.
    Xuan L; Wu X; Zhang Y; Fan Z; Ling Y; Huang F; Zhang F; Zhai X; Liu Q
    J Transl Med; 2011 Dec; 9():215. PubMed ID: 22171570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
    Hess AD; Thoburn CJ; Chen W; Bright AE
    Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.
    Gaschet J; Treviño MA; Cherel M; Vivien R; Garcia-Sahuquillo A; Hallet MM; Bonneville M; Harrousseau JL; Bragado R; Milpied N; Vié H
    Blood; 1996 Mar; 87(6):2345-53. PubMed ID: 8630397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.